Literature DB >> 14643822

Results of surgical treatment of T4 non-small cell lung cancer.

Cordula C M Pitz1, Aart Brutel de la Rivière, Henry A van Swieten, Cees J J Westermann, Jan-Willem J Lammers, Jules M M van den Bosch.   

Abstract

OBJECTIVE: Because of location and invasion of surrounding structures, the role of surgical treatment for T4 tumors remains unclear. Extended resections carry a high mortality and should be restricted for selected patients. This study clarifies the selection process in non-small cell T4 tumors with invasion of the mediastinum, recurrent nerve, heart, great vessels, trachea, esophagus, vertebral body, and carina, or with malignant pleural effusion.
METHODS: From 1977 through 1993, 89 patients underwent resection for primary non-small cell T4 carcinomas. Resection was regarded as complete in 34 patients (38.2%) and incomplete in 55 patients (61.8%). Actuarial survival time was calculated and risk factors for late death were identified.
RESULTS: Overall hospital mortality was 19.1% (n=17). Mean 5-year survival was 23.6% for all hospital survivors, 46.2% for patients with complete resection and 10.9% for patients with incomplete resection (P=0.0009). In patients with complete resection, mean 5-year survival for patients with invasion of great vessels was 35.7%, whereas mean 5-year survival for invasion of other structures was 58.3% (P=0.05). Age, mediastinal lymph node involvement, type of operative procedure, and postoperative radiotherapy did not significantly influence survival.
CONCLUSION: In certain T4 tumors complete resection is possible, resulting in good mean 5-year survival especially for tumors with invasion of the trachea or carina. High hospital mortality makes careful patient selection imperative.

Entities:  

Mesh:

Year:  2003        PMID: 14643822     DOI: 10.1016/s1010-7940(03)00493-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  Chest wall/parietal pleural invasions worsen prognosis in T4 non-small cell lung cancer patients after resection.

Authors:  Hiroshi Yabuki; Akira Sakurada; Shunsuke Eba; Fumihiko Hoshi; Hisashi Oishi; Yasushi Matsuda; Tetsu Sado; Masafumi Noda; Yoshinori Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-21

Review 2.  Extended resections of non-small cell lung cancers invading the aorta, pulmonary artery, left atrium, or esophagus: can they be justified?

Authors:  Emily S Reardon; David S Schrump
Journal:  Thorac Surg Clin       Date:  2014-09-11       Impact factor: 1.750

3.  Multiple instances of peripheral artery emboli from occult primary small cell lung cancer.

Authors:  Roberto Gabrielli; Maria Sofia Rosati; Roberto Chiappa; Silvio Vitale; Massimiliano Millarelli; Giovanni Caselli
Journal:  Tex Heart Inst J       Date:  2012

4.  Surface layer-preserving photodynamic therapy (SPPDT) in a subcutaneous mouse model of lung cancer.

Authors:  Masayoshi Kawakubo; Keisuke Eguchi; Tsunenori Arai; Koichi Kobayashi; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2012-06-29       Impact factor: 4.025

Review 5.  Surgical management of lung cancer.

Authors:  Adam Lackey; Jessica S Donington
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

6.  Total vertebrectomy for non-small cell lung cancer.

Authors:  Taiji Kuwata; Hidetaka Uramoto; Hajime Ohtomo; Eiichiro Nakamura; Fumihiro Tanaka
Journal:  Case Rep Oncol       Date:  2012-05-24

7.  Resection of thoracic malignancies infiltrating cardiac structures with use of cardiopulmonary bypass.

Authors:  Rawa Arif; Florian Eichhorn; Klaus Kallenbach; Philipp Seppelt; Arjang Ruhparwar; Hendrik Dienemann; Matthias Karck
Journal:  J Cardiothorac Surg       Date:  2015-06-25       Impact factor: 1.637

8.  Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer.

Authors:  Takahisa Eriguchi; Atsuya Takeda; Naoko Sanuki; Shuichi Nishimura; Yoshiaki Takagawa; Tatsuji Enomoto; Noriyuki Saeki; Kae Yashiro; Tomikazu Mizuno; Yousuke Aoki; Yohei Oku; Tetsuya Yokosuka; Naoyuki Shigematsu
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

9.  Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer.

Authors:  Yeon Joo Kim; Si Yeol Song; Seong-Yun Jeong; Sang We Kim; Jung-Shin Lee; Su Ssan Kim; Wonsik Choi; Eun Kyung Choi
Journal:  Radiat Oncol J       Date:  2015-12-30

Review 10.  Extended pneumonectomy for advanced lung cancer with cardiovascular structural invasions.

Authors:  Shi-Min Yuan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.